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1. Introduction 
DOPA decarboxylase (EC 4.1.1.26) has been ex- 
tensively studied, particularly regarding its distribution, 
specificity and inhibition; unfortunately, not much 
is known about its mechanism of action, and the 
mode of binding of the coenzyme (pyridoxal-S’-phos- 
phate) and the substrates. A study of the absorbance 
properties of the enzyme in the 300-500 mn range, 
where the bound coenzyme should show its charac- 
teristic absorption band, would be highly desirable, 
since similar studies have provided a good deal of in- 
formation in other pyridoxal phosphate dependent 
enzymes [ 1 ] . 
The poor stability of the mammalian enzyme, 
however, has made the purification and .the study 
of the properties of DOPA decarboxylase a difficult 
task. Recently, Christenson et al. [2] have obtained 
a homogeneous preparation from pig kidney; many 
structural features of the enzyme, but not its absorp 
tion spectra, have been described. In a preliminary 
report, we described a method which gave a highly 
purified enzyme [3] from the same source. 
In this report we shall illustrate the spectral fea- 
tures of the protein-bound coenzyme, showing that 
at least three different modes of binding may occur. 
Coenzyme appears to bind very tightly to the pro 
tein; in fact, Christenson et al. [2] were unable to re- 
solve the holoenzyme; in the present paper a method 
is described to dissociate reversibly the coenzyme from 
the protein; it will be shown that the reconstitution 
of the holoenzyme from the. apoenzyme and pyri- 
doxal phosphate restores the original spectral features. 
Furthermore, the spectral change caused by a- 
methyl-DOPA provides a clue. to explain the peculiar 
inhibitory action of this substrate analogue [4]. 
2. Methods 
The enzyme was purified from pig kidneys by a 
method outlined in a previous report [3] ; details of 
the preparation are given elsewhere [5] . The enzyme 
appeared to be homogeneous in polyacrylamide gel 
electrophoresis and at least 95% homogeneous in 
the ultracentrifuge; its coenzyme content (0.94 mole 
of coenzyme per 112,000 g of protein) is in excellent 
agreement with the content reported by Christen- 
son et al. (0.7- 1.1 mole/l 12,000 g). 
The activity was measured by the method of 
Christenson et al. (2) but with a shorter reaction 
time (2 min) and at lower temperature (30”). 
Pyridoxamine phosphate was determined by the 
method of Bossa and Barra [6], after treatment with 
sodium borohydride [7] to reduce the pyridoxal 
phosphate present. 
3. Results 
The absorption spectrum of the purified enzyme 
in the 300-500 nm region is shown in fig. 1. 
Two absorption maxima are present, respectively 
at 420 and 333 mn. The ratio of the intensity of the 
two peaks appears to be fairly constant in different 
enzyme preparations (A33s/&20 = 3.5-3.8). 
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Fig. 1. Absorption spectra of unmodified and reduced DOPA decarboxylase. The enzyme concentration is 10.4 mg/ml. - - - - - - : 
Enzyme in 0.1 M potassium phosphate buffer, pH 6.8; - : - . - . -: enzyme in 0.1 N NaOH; . . . . . . .: enzyme treated with 10 
mM sodjum borohydride; : sodium borohydride-treated enzyme in NaOH 0.1 N. 
The absorption spectrum does not change in the 
pH 7.5-6.0 region, where the enzyme is maximally 
active towards its best substrate, LDOPA. After addi- 
tion of NaOH to a final concentration of 0.1 N the 
spectrum of free pyridoxal phosphate appears. 
The peak at 420 nm, attributable to a Schiff base 
between the coenzyme and a protein amino group 
[ 1 ] is abolished by the addition of sodium borohy- 
dride, which is known to reduce such Schiff bases 
with the formation of pyridoxyl-compounds; unex- 
pectedly, however, the absorbance at 330 nm, which 
should increase as a result of the formation of the 
pyridoxyl compound, is slightly decreased (fig. 1). 
The addition of NaOH to the reduced enzyme in- 
duces the appearance of a small peak at 390 nm, 
corresponding to about 25% of the original coenzyme 
this means that 75% of the total coenzyme has been 
reduced by sodium borohydride. An interpretation 
of these data will be given in the discussion. 
Addition of hydroxylamine to the enzyme causes 
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Fig. 2. Effect of hydroxylamine and or-methyl-DOPA on the enzyme. The enzyme (10 mg/ml) was dissolved in 0.1 M potassium 
phosphatebuffer,pH6.8.------ :Enzyme; . . . . . . . . . . enzyme plus 0.1 M hydroxylamine; : enzyme plus 0.01 M 
or-methyl-DOPA (3 min after the addition of the inhibitor). 
the appearance of a peak at 390 nm (fig. 2) which is 
quite different from the absorption peak of the oxime 
formed with free pyridoxal phosphate, which absorbs 
maximally at 330 nm. 
The formation of the oxime with the protein-bound 
coenzyme is likely to weaken the coenzyme-apoen- 
?yme interaction; resolution of the hydroxylamine- 
treated holoenzyme has indeed proved possible. 
A typical resolution procedure is as follows: the 
enzyme is dialysed against three changes of a solution 
0.1 M of hydromlamine and low4 M EDTA, in 0.5 M 
potassium phosphate buffer, pH 6.5 at 4’; the en- 
zyme is then dialysed against three changes of the 
same phosphate buffer, containing low4 M EDTA. 
Four apoenzyme preparations had residual activi- 
ties ranging from 0 to 6% of the original value, and 
after addition of 10e6 M coenzyme exhibited acti- 
vities ranging from 35 to 56% of the original. The 
failure to obtain the full recovery of the original 
activity must be attributed to the inherent insta- 
bility of the enzyme; the apoenzyme should be even 
more labile, as is the case with other B6 dependent 
enzymes. 
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Fig. 3. Spectra of the apoenzyme and reconstituted holoenzyme. The enzyme (28 mg/ml) was dissolved in 0.5 M potassium phos- 
phate buffer, pH 6.5. - - - - - : Apoenzyme; : apoenzyme plus 1.4 X 10e4 M pyridoxal phosphate. 
The spectrum of the apoenzyme, shown in fig. 3, 
has no absorption maxima beyond 300 nm, except 
for a small shoulder at 330 nm. Upon addition of the 
coenzyme (half of the enzyme on a molar basis, so 
as to maintain a slight excess of native apoenzyme) 
the original spectrum of the holoenzyme is obtained 
(fig. 3). 
The addition of DOPA or Dopamine to the holo- 
enzyme leaves the spectrum practically unchanged. 
The spectral behaviour is markedly different after 
the addition of cu-methyl-DOPA, which is a power- 
ful inhibitor of DOPA decarboxylation, and under- 
goes a very slow decarboxylation [2]. cr-methyl- 
DOPA induces a relatively slow (t 1,2 = 2 min) de- 
crease of the absorption at 420 nm, with a corres- 
ponding increase in the 320 nm region (fig. 3). This 
suggests that at least part of the inhibitory action of 
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o-methyl-DOPA is due to a decarboxylation depen- 
dent transamination, analogous to that observed with 
a-methyl glutamate in the presence of glutamate de- 
carboxylase [8]. 
To test this hypothesis, an assay for pyridoxa- 
mine phosphate has been performed on an a-methyl- 
DOPA treated enzyme. After 10 min of reaction with 
0.01 M a-methyl-DOPA, 0.63 mole of pyridoxamine 
phosphate were formed per mole of enzyme, proving 
that transamination had indeed occurred. 
4. Discussion 
The 420 absorption peak of DOPA decarboxylase, 
commonly found in most B6 -dependent enzymes 
[l] , is attributable to a protonated Schiff-base in- 
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volving the aldehydic group of the coenzyme and 
an amino-group of a protein amino acid residue; in 
fact it disappears, as expected, following treatment 
either with NaBH4 or with hydroxylamine. 
The peak at 333 nm, also found in many B6-en- 
zymes [ 1 ] , is not, instead, unequivocally indicative 
of a particular coenzyme-protein complex; this ab- 
sorption band might originate from: (a) a substituted 
aldimine, usually inactive towards nucleophiles and 
devoid of coenzymatic activity; (b) a Schiff-base in 
an apolar medium [9] ; (c) other B6 derivatives lack- 
ing a double bond at the 4’ C. 
In our case several ines of evidence suggest hat 
this absorption originates from a catalytically active 
Schiff-base in an apolar medium; (a) the borohydride 
reduction leaves only 15% of the total coenzyme in 
a non-reduced state, yet the 333 mn absorbing form, 
judging from the known absorption coefficient of 
pyridoxal derivatives, should constitute about 60% 
of the total coenzyme. This indicates that a large 
percentage of the species absorbing at 333 nm is 
affected by reduction; (b) from the spectra of hy- 
droxylamine-treated holoenzyme, and in particular 
from the intensity of the peak at 390 nm, it can be 
deduced that hydroxylamine reacts with both the 
420 and the 333 nm absorbing forms; (c) resolution 
of the holoenzyme after hydroxylamine treatment 
causes a decrease of both the 420 and 333 nm ab- 
sorbing forms. (d) o-methyl-DOPA transforms over 
60% of the coenzyme into the pyridoxamine phos- 
phate form; (e) the fact that borohydride reduction 
does not increase the 333 nm peak is easily explained 
if a fraction of the coenzyme is located in an apolar 
environment: since the produced pyridoxyl com- 
pound in such an environment is expected to absorb 
below 300 nm [9]. Our data do not allow us to esta- 
blish whether the different modes of binding of the 
coenzyme originate from the existence of different 
protein species (e.g. conformers) or rather if an equi- 
librium is present between the “polar” and “apolar” 
binding mode. The latter situation has been pro- 
posed for tryptophan-synthetase [lo] , and could 
have mechanistic implication for the catalysis. 
A third, inactive form is present in our enzyme 
preparation, as shown by a fraction (about 25%) of 
non-reducible coenzyme, by the small amount of 
333 nm absorbing, inactive material present in the 
apoenzyme and by the incomplete transformation 
of the coenzyme, caused by cY-methyl-DOPA, to 
pyridoxamine phosphate. This inactive form has 
properties quite similar to those found in the y- 
form of aspartate transaminase from pig heart 
PII. 
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